BridgeMD
Tests treatment safety and results for Tinea Versicolor
Official title A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor
ClinicalTrials.gov ID: NCT05730244
What this study is testing
What is 20% Cassia alata cream?
20% Cassia alata cream is an investigational medicine, given as an once-daily treatment applied to the skin, being studied as a potential treatment for tinea versicolor.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to establish the efficacy of Cassia alata extract as a cream form in treating tinea versicolor (liver spots/shifting clouds). The main questions the study aims to answer are: Does the use of this extract help resolve tinea versicolor better than no treatment?
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- Patients aged 18-89 of either sex
- Clinical features suggestive of tinea versicolor AND Microscopic confirmation using skin scraping stains with chlorazol black preparation AND/OR...
- No treatment for versicolor in the preceding 4 weeks
- No contraindications to the application of C.alata cream including
- No history of allergy to C. alata
You likely can't join if
- Age \ 89 years
- Pregnant females
- History of hypersensitivity to C. alata or preservative
- Treatment within 4 weeks prior to enrollment
- Lesions which do not meet the diagnostic criteria of tinea versicolor
See the full eligibility criteria
- Patients aged 18-89 of either sex
- Clinical features suggestive of tinea versicolor AND Microscopic confirmation using skin scraping stains with chlorazol black preparation AND/OR Wood's lamp fluorescence
- No treatment for versicolor in the preceding 4 weeks
- No contraindications to the application of C.alata cream including
- No history of allergy to C. alata
- No history of preservative allergy
- Age \ 89 years
- Pregnant females
- History of hypersensitivity to C. alata or preservative
- Treatment within 4 weeks prior to enrollment
- Lesions which do not meet the diagnostic criteria of tinea versicolor
The study team makes the final eligibility decision.
Where it's taking place
- Kingston, Other, Jamaica
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kingston, Other, Jamaica. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.